ESC TV Today – Your Cardiovascular News

Host: Sabiha Gati Guest: Gianfranco Parati Want to watch this extended interview? Go to: https://esc365.escardio.org/event/2561?resource=interview Want to watch the episode? Go to: https://esc365.escardio.org/event/2561 Disclaimer: ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Sabiha Gati and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: honorary from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Gianfranco Parati has declared to have potential conflicts of interest to report: Merck Sharp and Dohme, Omron Healthcare, Viatris. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

This episode covers: Cardiology this Week: A concise summary of recent studies What's new in hypertension? Why I favour a critical approach in cardiology Snapshots Host: Sabiha Gati Guests: Konstantinos Koskinas, Gianfranco Parati, John Mandrola, Yasmina Bououdina Want to watch this episode? Go to: https://esc365.escardio.org/event/2561 Disclaimer: ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. Declarations of interests: Stephan Achenbach, Yasmina Bououdina, Sabiha Gati, Nicolle Kraenkel and John Mandrola have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: honorary from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Gianfranco Parati has declared to have potential conflicts of interest to report: Merck Sharp and Dohme, Omron Healthcare, Viatris. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Konstantinos Koskinas, cardiologist and news summarizer; Michiel Rienstra, academic AF guideline coordinator; Arian Sultan, interventional electrophysiologist specialized in ablation techniques; Jason Andrade, electrophysiologist expert in AF monitoring. They discuss AF burden and how to measure it. They explore pulsed field ablation: benefits, limits and wider uses. They cover post-ablation drug and anticoagulation strategies.

Thomas F. Luescher, cardiology expert and long-time clinician, explores AI, big data and the future of guidelines. He discusses datasets from imaging, wearables, genomics and registries. He covers continuous updates versus safety, validation and portability of prediction models, and the data skills clinicians will need. Practical ideas on streamlining guideline content and avoiding clinician alert fatigue are highlighted.

Michael Papadakis, a sports cardiology expert on hypertrophic cardiomyopathy, and Kostas Koskinas, an interventional cardiologist who summarizes recent studies. They discuss AI and big data shaping guideline development and living, continuously updated recommendations. They cover individualized risk scores, EHR integration, and new, personalized advice on exercise for people with hypertrophic cardiomyopathy.

Annemien van den Bosch, adult congenital heart disease specialist at Erasmus MC, discusses atrial septal defect imaging and management. She covers multimodality imaging choices. She outlines when surgery or device closure is preferred. She highlights lifelong specialised follow-up, pregnancy counselling, paradoxical embolism indications, and emerging bioresorbable and minimally invasive approaches.

Rasha Al-Lamee, interventional cardiologist researching angina and PCI. Roxana Mehran, expert in coronary revascularization. Annemien van den Bosch, adult congenital cardiologist focusing on atrial septal defects. JP Carpenter, cardiology commentator with study highlights. They discuss atrial septal defect diagnosis and closure strategies. They debate conservative versus invasive care for chronic coronary syndromes and review recent cardiovascular study headlines.

Borge Nordestgaard, a clinician-researcher from Copenhagen University Hospital known for his work on lipoprotein(a), discusses prevalence and strong genetic control of Lp(a). He explains Lp(a) biology, evidence linking it to calcific aortic valve stenosis, screening recommendations, current management strategies, and an ongoing trial testing major Lp(a) lowering to slow valve progression.

Hugh Montgomery, intensive care medicine chair focused on climate and health. JP Carpenter, cardiology commentator who summarizes recent studies. Borge Nordestgaard, cardiology professor known for Lp(a) research. They discuss Lp(a) links to aortic valve stenosis and emerging RNA therapies. They cover climate change’s immediate threats to cardiovascular health and practical mitigation and adaptation steps clinicians can take.

Fleur Tjong, a cardiology expert at Amsterdam UMC specializing in digital cardiology and AI in electrophysiology, engages in a rich discussion about the future of heart health. She explores how AI can predict atrial fibrillation risks using ECG data and emphasizes personalized approaches to monitoring. Fleur also highlights the importance of integrating wearable data into electronic health records without overwhelming clinics. Additionally, she discusses training for clinicians in digital tools, the health economics of remote monitoring, and her vision for AI's role in arrhythmia care over the next five years.